[{"Assets_0_Q2_USD":1520025000.0,"CommonStockSharesOutstanding_0_Q2_shares":37310142.0,"EarningsPerShareBasic_1_Q2_USD":0.17,"EarningsPerShareBasic_2_Q2_USD":0.61,"EarningsPerShareDiluted_1_Q2_USD":0.17,"EarningsPerShareDiluted_2_Q2_USD":0.6,"NetIncomeLoss_1_Q2_USD":6313000.0,"NetIncomeLoss_2_Q2_USD":22595000.0,"StockholdersEquity_0_Q2_USD":890573000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":37478000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":37475000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":37308000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":37294000.0,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20170209"}]